PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Overview Fund Activity
Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

93 hedge funds and large institutions have $92.2M invested in Paratek Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+2
Holders Change %
+2.2%
% of All Funds
1.84%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
14
Increased
38
Reduced
22
Closed
12
Calls
$350K
Puts
$414K
Net Calls
-$64K
Net Calls Change
-$309K

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$6.17M
2
AC
2
Armistice Capital
New York
$9.14M
3
GIM
3
Granahan Investment Management
Massachusetts
$2.87M
4
PM
4
Prosight Management
Texas
$1.81M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$1.05M

Top Sellers

1
BG
1
Baupost Group
Massachusetts
$0
2
RAM
2
Roumell Asset Management
Maryland
$1.37M
3
BlackRock
3
BlackRock
New York
$9.37M
4
RA
4
Royce & Associates
New York
$0
5
APCM
5
Arbiter Partners Capital Management
New York
$3.42M
Name Holding Trade Value Shares
Change 		Shares
Change %
SFSIG
101
San Francisco Sentry Investment Group
California
– -$1K -200 Closed
Daiwa Securities Group
102
Daiwa Securities Group
Japan
– -$1K -173 Closed
1 2 3 4
5